Testosterone Propionate: Clinical Trials

9 trials of Testosterone Propionate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 active not recruiting, 1 suspended. 9 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 19Completed 6, Active not recruiting 2, Suspended 1
Phase 21Suspended 1

Follow Testosterone Propionate: new trials by email Literature Review of Testosterone Propionate trials Research Report on Testosterone Propionate

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer
Biopsy, Bone Scan, Computed Tomography - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 1Active not recruitingRoswell Park Cancer Institute32024-12-192026-08-07
Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone
Best Practice, Quality-of-Life Assessment, Questionnaire Administration - Hypogonadism, Malignant Urinary System Neoplasm
Phase 1Active not recruitingEmory University562021-01-252026-05-26
Study of Exposure to Substances Prohibited by the World Anti-Doping Agency in Healthy Volunteers.
Bupropion, Anastrozole, Testosterone cyclopentylpropionate - Healthy Volunteers
Phase 1CompletedParc de Salut Mar92020-12-032021-04-26
Study of Testosterone and rHGH in FSHD
Testosterone Enanthate, Somatropin - Facioscapulohumeral Muscular Dystrophy
Phase 1CompletedUniversity of Rochester202017-12-182023-05-16
A Study of Axiron® in Healthy Participants
Axiron - Healthy Volunteers
Phase 1CompletedEli Lilly and Company122013-12-012014-08-19
A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in Healthy Participants
Testosterone, Deodorant Spray, Deodorant and Antiperspirant Combination Spray - Healthy Participants
Phase 1CompletedEli Lilly and Company302012-11-012014-10-16
CYP19A1 (Cytochrome P450 Family 19 Subfamily A Member 1) Gene and Pharmacogenetics of Response to Testosterone Therapy
Testosterone Cypionate - Hypogonadism
Phase 1CompletedVA Office of Research and Development1052011-10-012019-03-05
Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.
Testosterone propionate - Vaginitis, Dyspareunia
Phase 1 / Phase 2SuspendedUniversity of Vermont302006-12-012010-05-13
Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy
therapeutic testosterone - Prostate Cancer
Phase 1CompletedMemorial Sloan Kettering Cancer Center2000-02-012013-01-18

Conditions studied

Hypogonadism (2)  ·  Prostatic Neoplasms (2)  ·  Breast Neoplasms (1)  ·  Dyspareunia (1)  ·  Muscular Dystrophy, Facioscapulohumeral (1)  ·  Urologic Diseases (1)  ·  Urologic Neoplasms (1)  ·  Vaginitis (1)

Sponsors

Eli Lilly and Company (2)  ·  Emory University (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Parc de Salut Mar (1)  ·  Roswell Park Cancer Institute (1)  ·  University of Rochester (1)  ·  University of Vermont (1)  ·  VA Office of Research and Development (1)

Countries

United States (8)  ·  Spain (1)

Top investigators

Ana M Aldea Perona, MD PhD (1)  ·  Chad R Heatwole, MD, MS-CI (1)  ·  Hyman Muss, MD (1)  ·  Kenneth Ogan, MD (1)  ·  Marie Wood, MD (1)  ·  Michael Morris, MD (1)  ·  Reina C Villareal, MD (1)  ·  Sabrina M Witherby, MD (1)  ·  Saby George, MD (1)

Results publications

PMID 19375217, PMID 25123988, PMID 33735389, PMID 35027909, PMID 40900971

NIH funding

P01CA005826 (1), P30CA008748 (1), P30CA138292 (1)